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Summary
MNK1 is a serine/threonine kinase identified as a target for MAP kinase pathways. Using chemical drug, kinase-dead expression or knockdown
by RNA interference, we show that inhibition of MNK1 induces the formation of multinucleated cells, which can be rescued by expressing a
form of MNK1 that is resistant to RNA interference. We found that the active human form of MNK1 localises to centrosomes, spindle
microtubules and the midbody. Time-lapse recording of MNK1-depleted cells displays cytokinesis defects, as daughter cells fuse back together.
When MNK1 activity was inhibited, no microtubule defect at the midbody was detected, however, anchorage of the membrane vesicle at the
midbody was impaired as lumenal GFP-positive vesicles did not accumulate at the midbody. At the molecular level, we found that centriolin
localisation was impaired at the midbody in MNK1-depleted cells. As a consequence, endobrevin – a v-SNARE protein implicated in the
abscission step – was not properly localised to the midbody. Altogether, our data show that MNK1 activity is required for abscission.
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Introduction
Cytokinesis is a highly conserved mechanism that ends with the
cleavage of the mother cell into two daughters. This process is a
multi-step mechanism involving the assembly of an equatorial actin
and myosin contractile ring, which drives the rapid ingression of a
deep cleavage furrow (Field et al., 1999; Glotzer, 2001; Guertin
et al., 2002; Zeitlin and Sullivan, 2001). However, although the
furrowing is necessary for cytokinesis, it is not sufficient to allow the
topological separation of daughter cells. Indeed, furrowing proceeds
until the cytoplasm is constricted to a narrow microtubule bridge,
known as the midbody. Thus, the terminal event of cytokinesis is the
abscission of the intercellular bridge leading to the separation of the
two daughter cells. Factors involved in the formation, maintenance
and resolution of this bridge are largely unknown (Echard et al.,
2004). During mitosis in plant, members of the MAPK family
localise to the cell plate as active kinases (Bo¨gre et al., 1999;
Calderini et al., 1998) and were found to be involved in cytokinesis
(Nishihama and Machida, 2001; Sasabe et al., 2006). In mammalian
cells, the MAPK ERK2 directly phosphorylates the centrosome
protein CEP55, which induces its relocalisation to the midbody,
where it actively participates in cytokinesis (Fabbro et al., 2005).
Here, we focused on a kinase downstream of ERK2, MNK1, a
serine/threonine kinase identified during screens that are designed
to search for ERK substrates (Fukunaga and Hunter, 1997;
Waskiewicz et al., 1997). Mammalian MNK1 is also a substrate
for the stress-activated p38 MAPK (Tanoue et al., 2000), thereby
placing MNK1 as a downstream kinase in the MAPK pathways
(Morley, 1997; Wang et al., 1998). MNK1 has been known for a
long time to phosphorylate eukaryotic translation initiation factors
(eIF4E), which are involved in cap-dependent mRNA translation
(Waskiewicz et al., 1999; Wang et al 1998; Morley, 1997). In
Drosophila melanogaster, Lk6 was identified as theMnk orthologue
because both kinases share sequence similarities, conserved residues
and domains, and because Lk6 phosphorylates eIF4E in vivo and is
a downstream target of ERK2 (Arquier et al., 2005, Parra-Palau
et al., 2005). Interestingly, Lk6 was found to interact with
microtubules in vitro and to localise to centrosomes (Reiling et al.,
2005; Kidd and Raff, 1997). Overexpression of Lk6 also induced
defects in the organization of microtubules in eggs and embryos,
such as mitotic spindle defects, with centrosomes detaching from the
spindle poles (Kidd and Raff, 1997). However, clear mitotic
functions of Lk6/MNK1 have never been found.
Here, we provide experimental evidence for a new function of
MNK1 kinase during mitosis. MNK1 drug treatment, kinase-dead
expression and RNAi downregulation induce the formation of
multinucleated cells. The active form of MNK1 is localised to
the midbody. Time-lapse recording of live cells shows that
microtubules are not affected at the midbody in the absence of
MNK1. Inhibition of MNK1 activity eliminates the accumulation
of lumenal GFP-positive vesicles at the midbody before abscission.
Those vesicles are required to repair damage to the plasma
membrane during abscission. At the molecular level, knockdown of
MNK1 by RNAi disrupts the localisation of centriolin to the
midbody during cytokinesis. In the absence of centriolin, the v-
SNARE protein endobrevin, which is required for abscission, is
also found mislocalised to the midbody. Thus, MNK1 kinase
activity is required for abscission, the terminal step of cytokinesis.
Results
Inhibition of MNK1 induces multinucleated cells
We started to investigate MNK1 function by treating proliferating
HeLa cells with the Novartis inhibitor CGP57380 at 20 mM for
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48 hours. Following the drug treatment, 30% (61.5) of the cells
were found to be multinucleated (more than two nuclei) whereas
,5% (60.5) of the control cells were multinucleated (Fig. 1A).
Because CGP57380 inhibits both MNK1 and MNK2, we
investigated whether the appearance of multinucleated cells was
due to MNK1 inhibition by using a dominant-negative approach,
and compared the effect of expressing either active wild-type
MNK1 or kinase-dead MNK1 (Pyronnet and Sonenberg, 2001).
While overexpression of wild-type MNK1 slightly increased the
number of multinucleated cells by 4% (60.5), overexpression of
the kinase-dead MNK1 increased this number up to 16% (61)
(Fig. 1B). These two experiments using the inhibitor CGP57380
and the kinase-dead MNK1 indicate that the kinase activity of
MNK1 is required to avoid the formation of multinucleated cells.
We then used an RNA interference approach to more specifically
knockdown expression of MNK1. Three different siRNAs were
designed against MNK1 mRNA sequences, and 72 hours after
siRNA transfection, MNK1 was not detected by western blot
(supplementary material Fig. S1). Cells were fixed, stained for
microtubules, DNA and centrosomes, and then observed under
an epifluorescent microscope. A total of ,3% (61.5) of
multinucleated cells were consistently observed in the control,
whereas an average of 22% (65) of multinucleated cells were
found in cells harbouring a reduced expression of MNK1
(Fig. 1C). Among the population of multinucleated cells, 30% of
them had more than two nuclei, indicating that nuclear division
was not affected. We did not observe any micronulei, as nuclei
were regular in size and shape. However, cell divisions did not
occur, strongly suggesting that the lack of MNK1 induced a
cytokinesis defect. Multinucleated cells also contained an
abnormal number of centrosomes, consistent with a cytokinesis
defect. We have eliminated the possibility that the formation of
multinucleated cells was due to a lack of eIF4E phosphorylation by
overexpressing a mutant form of eIF4E-S209A that cannot be
phosphorylated by MNK1 (Ueda et al., 2004; O’Loghlen et al.,
2004). Unlike the inhibition of MNK1, overexpression of eIF4E-
S209A did not induce the formation of multinucleated cells
(supplementary material Fig. S2). Although p38 and ERK1/2 are
placed upstream MNK1, their inhibition does not induce the
formation of polyploid cells (data not shown). Knockdown of
MNK1 expression by RNA interference did not affect the level of
ERK1and ERK2 proteins (data not shown). To ensure that the
observed phenotype was due to a lack of MNK1, we decided to
rescue the treatment of MNK1 siRNA by expressing a GFP-tagged
MNK1 resistant to the siRNA. Both MNK1 siRNA and the
expression vector were transfected into HeLa cells. Depletion of
the endogenous MNK1 and expression of RNAi-resistant GFP-
tagged MNK1 protein expression were analyzed by western blot
using antibodies against MNK1 and GFP. Control siRNA did not
induce any decrease in MNK1 expression (Fig. 2A, lanes 1 and 2),
Fig. 1. Inhibition of MNK1 induces polyploidy. (A) Inhibition of MNK1
with CGP57380 induces multinucleation. Cells were incubated with 20 mM
CGP57380 or 1% DMSO (as a control) for 48 hours, then fixed and stained for
microtubules (green) and DNA (blue). (B) Overexpression of inactive but not
wild-type MNK1 induces multinucleation. Cells were transfected with a vector
expressing the FLAG alone or an active FLAG–wt-MNK1 (WT MNK1) or an
inactive FLAG-TAA-MNK1 (kinase-dead MNK1). Cells were fixed 72 hours
after transfection and stained with an anti-FLAG antibody (red) and DAPI
(blue). (C) Depletion of MNK1 using siRNA induces multinucleation. Cells
were transfected with MNK1 siRNA or control siRNA. MNK1 protein level
was monitored by western blot 72 hours after transfection (b-tubulin was used
as a loading control). Cells were fixed and stained for DNA (blue),
microtubules (green), and centrosomes (red). Scale bars: 30 mm.
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while siRNA directed against MNK1 eliminated its expression
(Fig. 2A, lanes 3 and 4). GFP expression (Fig. 2A, lanes 2 and 4)
and MNK1–GFP (Fig. 2A, lanes 1 and 3) were, as expected,
insensitive to RNAi. These cells were then fixed and stained for
DNA (Fig. 2B). The number of multinucleated cells was
quantified by fluorescence microscopy (Fig. 2C). The number of
multinucleated cells treated with control siRNA expressing GFP or
GFP–MNK1 was equivalent (4% 60.5 versus 3.5% 60.9, n55,
.300 cells per experiment, t-test P50.2). By contrast, whereas
expression of GFP had no effect on the number of multinucleated
cells induced by MNK1 siRNA (13% 61.5), expression of GFP–
MNK1 rescued multinucleation (13% 61.5 versus 4.5% 60.6,
n55,.300 cells per experiment, t-test P50.0004). This last result
unambiguously demonstrated that the lack of MNK1 is responsible
for polyploidy.
The activated phosphorylated form of MNK1 localises to
mitotic structures
To understand how MNK1 kinase could be necessary to avoid
multinucleation, we examined the localisation of MNK1 and
active MNK1 by using antibodies raised against MNK1
phosphorylated at Thr197 and Thr202 (Waskiewicz et al.,
1999). MNK1 localised to the cytoplasm and nucleus through
out the cell cycle (McKendrick et al., 2001; Parra-Palau et al.,
2003). During interphase, the phosphorylated form of MNK1 was
hardly detectable, except for a weak signal in the nucleus. In
prophase, phosphorylated MNK1 was clearly concentrated at the
centrosome (Fig. 3A, white arrow). The activated kinase was
then both found at the centrosomes and on the spindle in
metaphase, and at the centrosomes and central spindle
microtubules in anaphase. In telophase, MNK1 was no longer
detectable at the centrosome, but was entirely relocalised to the
central spindle and remained on the midbody during cytokinesis.
This result indicated that activated MNK1 localised to mitotic
structures. During cytokinesis, active MNK1 was detected on
both sides of the central ring, and MNK1 RNAi greatly reduced
this localisation, demonstrating the specificity of the antibodies
used (Fig. 3B). This last localisation is in agreement with a
control for the formation of multinucleated cells by MNK1.
Depleted MNK1 cells undergo multinucleation owing to a
cytokinesis defect
In order to visualise how and when cell division was affected by
MNK1 depletion, HeLa cells treated with MNK1 siRNA were
recorded using Hoffman contrast video microscopy (Fig. 4A;
supplementary material Movies 1, 2). The first stages of mitosis
appeared normal in MNK1-depleted cells, as they proceeded to
cytokinesis in the same way as the control cells. Midbody
abscission occurred ,3–4 hours after the metaphase–anaphase
transition. The cells then separated and the flemming body (or
central ring) was inherited by one daughter cell (Fig. 4A, control
black arrows). By contrast, MNK1-depleted cells did not separate
as cytokinesis aborted, and the two daughter cells fused back
together to form a single binucleated cell (Fig. 4A, MNK1 RNAi
black arrows). The movie clearly shows a cytokinesis defect in
absence of MNK1 (supplementary material Movie 2).
Microtubule network at the midbody is not affected in
MNK1-depleted cells
To gain a deeper insight into how cytokinesis was affected by the
lack of MNK1, we recorded HeLa cells expressing GFP-tagged
tubulin, and investigated whether MNK1-depletion affects the
microtubule network from metaphase to abscission. MNK1-
depleted cells progressed normally through mitosis until
cytokinesis just like the control cells. The midbody first formed
a thick, stable and straight microtubule intercellular bridge. This
bridge became thinner and a flemming body eventually formed.
During abscission, the midbody disappeared and the residual
flemming body was inherited by one of the daughter cells. In
order to follow the evolution of the microtubule network at the
midbody during cytokinesis, we used cells expressing tubulin–
GFP and defined three types of cell: (1) cells with a thick
Fig. 2. Polyploidy phenotype of MNK1-depleted cells is rescued by
expressing a GFP–wt-MNK1 RNA that is resistant to RNAi. Cells were co-
transfected with a vector expressing siRNA-resistant GFP–wt-MNK1 or GFP
alone, and with MNK1 siRNA or control siRNA. (A) Extracts from cells
transfected with GFP (lanes 2 and 4) or GFP–wt-MNK1 (lanes 1 and 3) with
MNK1 siRNA (lanes 3 and 4) or with control siRNA (lanes 1 and 2) were probed
with antibodies against GFP and MNK1. Note the depletion of endogenous
MNK1 (lanes 3 and 4) whereas GFP–wt-MNK1 protein levels are unaffected
(lane 3). b-tubulin western blot is used as a loading control. (B) At 72 hours after
transfection, cells were fixed and stained for DNA (blue), GFP proteins appear
in green. Scale bar: 30 mm. (C) Statistical analysis of the multinucleation rescue
by GFP–wt-MNK1 and GFP (5 experiments).
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midbody, (2) cells with a thin mibody and without a flemming
body and (3) cells with a thin midbody with a clear flemming
body (Fig. 4B). We did not find any differences in the
microtubule network at the midbody in asynchronous cells with
or without MNK1 (Fig. 4C). In order to compare more precisely
cytokinesis in normal and MNK1 depleted cells, we synchronized
the cells in the G2-M transition using the CDK1 inhibitor RO-
3306. Cells were then released and fixed at different times (2, 3
and 4 hours after release). The number of cells at each stage,
which we defined by the shape of the midbody, was again
identical in control and MNK1-depleted cells. Starting from
metaphase, numbers evolved identically, indicating that we could
not detect any difference with or without MNK1 (Fig. 4D).
Together, these results suggest that the kinase does not control
the microtubule network at the midbody.
Fig. 4. MNK1 depletion triggers a cytokinesis defect. (A) Selected frames
from a time-lapse recording of HeLa cells using Hoffman contrast during
mitosis in control cells (top, supplementary material Movie 1) or MNK1
depleted cells (bottom, supplementary material Movie 2). Time is in hours and
minutes. (B) Typical midbody morphology during cytokinesis. Three
populations of midbody have been considered: thick midbody (left, green), thin
midbody without the flemming body (middle, blue) and thin midbody with the
flemming body (right, red) (C) Distribution of the three midbody populations in
asynchronous HeLa cells expressing a-tubulin–GFP treated with control (left)
or MNK1 siRNA (right) for 72 hours; cells were fixed in 3.7% formaldehyde in
PHEM. (D) Quantification of three midbody populations in synchronous HeLa
cells expressing a-tubulin–GFP treated with control (square) or MNK1 siRNA
(triangle) for 72 hours; cells were arrested in metaphase by treating with 10 mM
of CDK1 inhibitor IV RO-3306 over the course of 20 hours, then released and
fixed 2, 3 or 4 hours after removal of RO-3306.
Fig. 3. Subcellular localisation of active MNK1. (A) Localisation of
phosphorylated MNK1 (see Materials and Methods) during mitosis. Cells
were fixed and stained for microtubules (green), DNA (blue) and
phosphorylated MNK1 (red). A strong staining of phosphorylated MNK1 on
the microtubules spindles (from prophase to telophase) and on the midbody
during cytokinesis can be observed. Scale bars: 10 mm. (B) Specificity of
phosphorylated-MNK1 localisation during cytokinesis. Cells treated with
control (top) or MNK1 (bottom) siRNA were stained for microtubules (green)
and phosphorylated MNK1 (red). Scale bar: 2.5 mm.
MNK1 regulates abscission 2847
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
MNK1 is required for accumulation of membrane vesicles
to the midbody before abscission
Targeted membrane addition during cleavage furrow formation is
a fundamental and widely conserved mechanism of animal
cytokinesis (Albertson et al., 2005). When abscission starts,
membrane vesicles are recruited at the midbody where they fuse
with the plasma membrane to trigger intercellular-bridge
abscission. To gain a deeper insight and analyse whether
membrane trafficking was affected in the absence of MNK1, we
decided to analyse the dynamics of the traffic by using lumenal
GFP as a marker (Blum et al., 2000). HeLa cells were transfected
with the plasmid encoding lumenal GFP that labelled membrane
vesicles. The stable pooled population of transfected cells was
incubated for 6 hours either with CGP57380 to inhibit MNK1 or
DMSO, and the trafficking of lumenal GFP was filmed live from
metaphase to abscission by using spinning confocal microscopy.
Analysis of lumenal GFP movement revealed that although
recruitment and accumulation of lumenal GFP were clearly
observed at the midbody in the control cells before abscission,
lumenal GFP was barely detectable at the midbody in the presence
of CGP57380 (Fig. 5A; supplementary material Movies 3, 4).
GFP-fluorescence intensity at the midbody was quantified and
compared in 13 different movies, with or without MNK1. The data
obtained clearly show that lumenal GFP was not recruited at the
midbody when MNK1 expression was inhibited (Fig. 5B). This
strongly suggests that the defect in membrane-vesicle recruitment
and accumulation at the midbody induced by the inhibition of
MNK1 activity is responsible for the cytokinesis defect observed.
MNK1 is required for endobrevin localisation at the
midbody before abscission
As we found a defect in the recruitment of membrane vesicles at
the midbody, we checked whether the localisation of the vesicle-
fusion SNARE complexes that normally come with the vesicles
at the midbody were affected in the absence of MNK1. We used a
cell line expressing GFP-tagged a-tubulin to visualise the
microtubules and examine the localisation of the vesicle-
associated membrane protein 8 (VAMP8 or endobrevin). When
abscission starts, endobrevin moves to the central ring where the
membrane vesicles fuse with the plasma membrane and triggers
intercellular-bridge abscission (Gromley et al., 2005; Low et al.,
2003). Typically, during cytokinesis, endobrevin localises to the
midbody on both sides of the flemming body (Fig. 6A). We
analysed the localisation of endobrevin and recorded three
different types of localisation – (1) normal as in Fig. 6A, (2)
central but without the flemming body and (3) abnormal – all
Fig. 5. MNK1 is required for membrane vesicle recruitment and
accumulation at the midbody. (A) Selected frames from the time-lapse
recording of HeLa cells expressing lumenal GFP during cytokinesis in control
cells (left, supplementary material Movie 3) or in CGP57380-treated cells
(right, supplementary material Movie 4). Cells were observed from metaphase
to abscission. Every 2 minutes, a z-series was acquired in fluorescence.
Spinning confocal images are the maximal intensity projection of the entire Z-
stack. In control cells, lumenal GFP clearly accumulates on the flemming body,
whereas it is only weakly detectable on the flemming body of CGP57380-
treated cells (white arrows). Time is in minutes. (B) Quantification of the
lumenal GFP fluorescence signal at the flemming body during cytokinesis. At
the end of telophase, a 10610 pixel square was positioned on the flemming
body to measure GFP intensity after maximal-intensity projections were
calculated from the original three-dimensional data sets. The background was
measured outside the cells and subtracted.
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along the microtubules between the two daughter cells. We
observed a normal localisation in 87% (64) of control cells,
whereas central staining was only found in 3% (61.5) of control
cells and no abnormal localisation was observed. On the contrary,
only 22% (61.2) of MNK1-depleted cells showed central
staining and 26% (62.5) showed an abnormal localisation of
endobrevin with a reduced signal compared with control cells
(Fig. 6B). Because the endobrevin protein level was not affected
in the absence of MNK1 (Fig. 5C), our interpretation of these
data was that MNK1 activity is required for endobrevin
localisation to the midbody before abscission.
MNK1 is required for centriolin localisation to the midbody
before abscission
Endobrevin localisation to the midbody depends on the presence
of centriolin at the midody (Gromley et al., 2005). Centriolin was
first identified as a centrosome protein (Gromley et al., 2003).
It localises to the mature centriole throughout cell cycle
progression, and upon transition of metaphase to anaphase, a
pool of centriolin relocalises to the midbody where it is required
for the late stage of cytokinesis (Gromley et al., 2005). Typically,
centriolin localises as a ring shape to the midbody (Fig. 7A). We
observed that in the absence of MNK1, the number of cells
showing centriolin at the midbody decreases from 80% to 50%
(Fig. 7B). This was not due to a lack of centriolin synthesis, as
we did not observe any decrease in the level of centriolin protein
in the absence of the MNK1 (Fig. 7C), indicating that MNK1 is
required for localisation of centriolin to the midbody, and that the
lack of centriolin at the midbody leads to a defect in the
localisation of endobrevin.
Fig. 7. MNK1 is required for centriolin localisation to the midbody.
(A) Localisation of centriolin during cytokinesis in control cells. Cells
expressing GFP–a-tubulin (green) were fixed, stained for DNA (blue) and
centriolin (red). Scale bar: 5 mm. Centriolin appeared as a small ring shape
around the flemming body (small panel, middle). (B) Cells were treated with
control or MNK1 siRNA for 72 hours, fixed and stained for centriolin and
DNA. The number of cells showing centriolin at the midbody was estimated
in both cases. (C) Depletion of MNK1 using siRNA had no effect on the level
of centriolin as shown by the western blots monitoring MNK1, centriolin and
b-tubulin, used as a loading control.
Fig. 6. MNK1 is required for localisation of endobrevin at the midbody.
(A) Localisation of endobrevin during cytokinesis in control cells. Cells
expressing GFP–a-tubulin (green) were fixed, and stained for DNA (blue) and
centriolin (red). Scale bar: 5 mm. Endobrevin appeared as two dots at each side of
the flemming body (small panel, right). (B) Cells were treated with control or
MNK1 siRNA for 72 hours, and fixed and stained for endobrevin and DNA. The
number of cells showing normal endobrevin localisation (top panel), central
localisation (middle panel) and abnormal localisation (lower panel) at the midbody
was estimated in control andMNK1-depleted cells. (C) Depletion ofMNK1 using
siRNA had no effect on the level of endobrevin, as shown by the western blots
monitoring MNK1, endobrevin and b-tubulin, used as a loading control.
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MNK1 is not required for Mklp1 localisation to the midbody
before abscission
In order to get a deeper insight into the mechanism controlled by
MNK1, we checked the localisation of the kinesin-like protein
MKLP1 (also known as KIF23). MKLP1 is a component of the
centralspindlin complex (Mishima et al., 2002), which behaves
like a chromosome passenger protein (Kuriyama et al., 2002). It
was reported that centriolin localisation was under the control of
MKLP1 (Gromley et al., 2005). We monitored the midbody
localisation of MKLP1 and did not find any defect in the absence
of MNK1 (supplementary material Fig. S3). The data clearly
suggest that MNK1 activity can be positioned after MKLP1 and
before centriolin in a mechanism that directs cytokinesis through
endobrevin localisation. Several other proteins involved in
cytokinesis were also controlled. The chromosome passenger
protein Aurora-B localised properly to the midbody
(supplementary material Fig. S3) (Terada et al., 1998). The
localisation of the ERK2 substrate CEP55 was not impaired
either (supplementary material Fig. S3).
Discussion
During proliferation, at each cell cycle, every cell divides to give
two genetically equivalent daughter cells. Every cycle results in
the physical separation of the two daughter cells. This is a
complex and crucial step in the life of the cell. The position of the
cleavage machinery will determine the size of each daughter cell
(Oliferenko et al., 2009). The plasma membrane must be broken
and repaired without allowing leakage of the cytoplasm
(McCollum, 2005; Baluska et al., 2006; Montagnac et al.,
2008). Before this final stage, the two cells remain linked by an
intercellular bridge made of anti-parallel microtubules associated
with many vesicular structures that will be used to repair the
plasma membrane (McIntosh et al., 1971). These membrane
vesicles are imported from the two daughter cells to fuse with the
plasma membrane. In the intercellular bridge, at the middle of the
midbody, a ring structure serves as an anchoring point for theses
membrane vesicles (Mishima et al., 2002; Zeitlin and Sullivan,
2001).
Here, we present evidence that without MNK1 activity this
mechanism is impaired, leading to a defect in cytokinesis that
eventually results in the fusion of the two daughter cells. MNK1
is a protein kinase that belongs to the MAPK pathway. It is
responsible for the inducible phosphorylation of eIF4E at Ser209
in mammals (Waskiewicz et al., 1999). The exact function of this
serine phosphorylation in not known (Scheper and Proud, 2002).
It has been reported that suppression of eIF4E phosphorylation by
using MNK1 inhibitor CGP57380 or MNK1 knockout in mouse
has no effect on the initiation of cap-dependent translation.
Although MNK1 is essential for phosphorylation of eIF4E, the
function associated with this phosphorylation is not precisely
defined. In Drosophila the kinase seems to be required for growth
and development (Arquier et al., 2005). When we found that
inhibition of MNK1 led to the formation of multinucleated cells,
we immediately investigated whether the same phenotype could
be obtained by overexpression of unphosphorylatable eIF4E. This
was not the case, strongly suggesting that the phenotype observed
was not due to a lack of mRNA translation. However, each time
we observed a protein localisation defect in the absence of
MNK1, we systematically investigated whether the level of the
protein was affected. We did not find any change in the level of
endobrevin or centriolin proteins in the absence of MNK1.
However, the localisation of both proteins was affected. The
number of cells showing the localisation of endobrevin and
centriolin to the midbody was strongly decreased in the absence
of MNK1. Endobrevin localisation to the midbody requires the
presence of centriolin, thus, we suggest that the absence of
endobrevin from the midbody is due to the mislocalisation of
centriolin. We then checked the localisation of MKLP1 and
found that it was not affected by the absence of MNK1. Because
the presence of centriolin at the midbody depends on the
localisation of MKLP1, we suggest that MNK1 activity is
required for centriolin localisation to the midbody independently
of MKLP1 (Fig. 8). We are now currently investigating whether
centriolin could be a direct target of MNK1. Both proteins move
together during mitosis. They both localise to the centrosome at
the beginning of mitosis, and they are both present at the
midbody before abscission. Our working hypothesis is that the
phosphorylation of centriolin would be required for its
localisation from the centrosome to the midbody, and MNK1
would be required directly or indirectly in these phosphorylation
events. In the absence of MNK1, we observed a defect in the
localisation of centriolin that leads to a mislocalisation of
endobrevin, resulting in a defect in the anchorage of membrane
vesicles at the midbody. The chain of events eventually results in
an abortion of abscission and a fusion of the two daughter cells to
form a binucleated cell. All these data clearly demonstrate for the
first time that MNK1 activity is required for abscission.
Materials and Methods
Reagents and antibodies
The following primary antibodies were used: goat polyclonal anti-MNK1 (C-20)
(1:1000 for IF and 1:500 for western blot, Santa-Cruz Biotechnology), mouse
Fig. 8. MNK1 is required for centriolin localisation to the midbody
independently of the presence of Mklp1. In the chain of events leading to
cytokinesis defects in the absence of MNK1, we found that even in the presence
of MKLP1, centriolin was mislocalised, inducing endobrevin-localisation
defects leading to defects in the anchorage of membrane vesicles and eventually
abortion of cytokinesis. These data indicate that MNK1 activity is required after
MKLP1 localisation and before centriolin localisation.
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anti-phosphorylated-MNK1 (Thr197 and Thr202) (1:100, Cell Signaling), mouse
anti-b-tubulin (1:2000, clone 2.1, Sigma Chemicals), mouse anti-c-tubulin
(1:2000, clone GTU-88, Sigma Chemicals), mouse anti-GFP (2 mg/ml, clones
7.1 and 13.1, Roche), mouse anti-FLAG (1:1000, Stratagene), rabbit anti-
endobrevin (1:1000, gift from Thomas Weimbs), mouse anti-citron kinase
(CRIK) (1:1000, BD Transduction Laboratories), rabbit anti-MLKP1 (N-19)
(1:1000, Santa-Cruz Biotechnology) and rabbit anti-Rab11 (1:100) antibodies.
MNK1 inhibitor CGP57380 was from Novartis (20 mM in DMSO). CDK1 RO-
3306 was from Calbiochem.
Plasmid construction and siRNA
siRNA-resistant GFP–MNK1 was obtained by double PCR of MNK1 in pOTB7
(Mammalian Gene Collection: access number: 3629765). Primers used for the first
amplification were: 59-CTCGAGGTATCTTCTCAAAAGTTGG-39, 59-GAAGC-
AAAAGCACTTTAACGAACGGGAGGCCAGCCGAGTGGTGC-39, 59-CCGCG-
GTGGAGCATTTCAGAGTGCTGT-39 and 59-GCACCACTCGGCTGGCCTCC-
CGTTCGTTAAAGTGCTTTTGCTTC-39 (mutations are underlined). Primers used
for the second amplification were: 59-CTCGAGGTATCTTCTCAAAAGTTGG-39
(XhoI) and 59-CCGCGGTGGAGCATTTCAGAGTGCTGT-39 (SacII) (restriction
sites are underlined). The PCR products were cloned into pEGFP-C3 (Clontech).
Human MNK1 siRNA oligonucleotide (59-UUCUCGCUCAUUGAAGUGC-
39) was purchased from Eurogentec. Random siRNA was used as a control
(Petretti et al., 2006). plum–GFP was provided by Irene Schultz (Blum et al., 2000).
Cell culture and transfection
Control HeLa cells or HeLa cells stably expressing GFP-tagged a-tubulin were
maintained in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal
calf serum. For RNA interference, 150 pmoles of siRNA were mixed with 6 ml of
Oligofectamine (Invitrogen, Life Technologies) and applied to cells grown on 12-
well culture plates with a confluency of 40%. For rescue assays, cells were
transfected with both 150 pmoles of siRNA and 1.6 mg of GFP–MNK1 or pEGFP-
C3 vector using Lipofectamine. Cells were cultured for 72 hours before analysis.
For lumenal GFP, Hela cells were transfected with plumGFP with JetPrime
transfection reagent (Polyplus transfection). The stably transfected pooled
population obtained after selection with G418 was used for live-cell imaging.
Indirect immunofluorescence staining
Cells grown on glass coverslips were fixed in –20 C˚ methanol for 10 minutes or
4% paraformaldehyde. Cells were incubated for 1 hour in PBS plus 0.05% Tween-
20 (PBST) containing 5% BSA followed by a 2-hour incubation in PBST-BSA
containing primary antibodies. Secondary antibodies were applied for 1 hour at
room temperature. Phosphorylated MNK1 was stained with tyramide, as indicated
by the manufacturer (TSA Plus Fluorescence Sytems, Perkin Elmer). Coverslips
were mounted in Vectashield containing DAPI (Vector Laboratories). A Leica
DMIRE2 inverted SP2 confocal microscope using a Plan Apochromat 636HCX
PL APO (NA 1.4) objective was used (Figs 3, 5). For each image, a single confocal
plane was presented. For others figures, z-series were acquired using a Leica
DMRXA2 fluorescent microscope with a 636HCX PL APO (NA 1.32) objective
and a CoolSnap ES camera (Roper Scientific). The maximum projection of the
deconvoluted Z-series was processed by Metamorph software (Universal Imaging).
Figures were prepared using Photoshop (Adobe).
Immunoblot analysis
Western blots were performed as described previously (Petretti et al., 2006).
Live-cell imaging
HeLa-lumGFP cells (lumenal-GFP-expressing HeLa cells) were grown in a Lab-
Tek I chambered coverglass (Nunc). Cells were treated for 6 hours with either
DMSO or with 20 mM CGP57380 (Sigma). Before transferring to the microscope,
the medium was changed to CO2-independent medium supplemented with 10%
FBS and 200 mM L-glutamine (Invitrogen). Time-lapse images were captured
using a Plan Apo 606 (NA 1.4) objective on an Eclipse Ti-E microscope (Nikon)
equipped with a spinning disk (CSU-X1; Yokogawa), a thermostatic chamber (Life
Imaging Service), a Piezo Z-stage microscope (Marzhauser), and a charge-coupled
device camera (CoolSNAP HQ2; Roper Scientific). Metamorph Software
(Universal Imaging) was used to collect the data. GFP frames were recorded
every 5 minutes until cells entered anaphase and then every 2 minutes. Images are
a maximum projection of 20 Z-planes acquired 0.6 mm apart. Time-lapse data
were processed using Metamorph and ImageJ (NIH).
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